Fetal bovine serum (FBS) is one of the primary components of animal cell culture media. FBS is collected from bovine fetuses taken during slaughter of pregnant cows. The key factor driving growth of the global fetal bovine serum market is its high demand from the in-vitro cell culture applications coupled with significant demand from the pharmaceutical and biotechnology industries. Fetal bovine serum is a byproduct of meat processing industry. With increasing concerns over meat consumption and its environmental impacts, the global meat processing industry is anticipated to witness slowdown in coming years. This is anticipated to hinder the growth of global fetal bovine serum market.
The global fetal bovine serum market is expected to expand at a CAGR of 5.0% during the forecast period. The global fetal bovine serum market is consolidated with limited number of global players holding major share of the market.
North America sourced FBS is one of the key market segments whereas, South America sourced FBS represents the fastest growing market segment. The key players active in the global fetal bovine serum market include Merck KGaA, Bovogen Biologicals Pty Ltd, Atlanta Biologicals Inc. (Bio-Techne Corporation), Thermo Fisher Scientific, GE Healthcare, Tissue Culture Biologicals, HiMedia Laboratories, TCS Biosciences Ltd., Rocky Mountain Biologicals and PAN-Biotech.
The report titled “Fetal Bovine Serum Market - Global Market Share, Trends, Analysis and Forecasts, 2022-2032” wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global fetal bovine serum market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, security & exchange overview, research & development activities, production facilities, product portfolio, employee strength, and key executive, for all the players considered under the scope of study. For instance, Merck Millipore’s Life Sciences segment that comprises FBS fares highest in North America. This segment accounts for about 56.9% share in Merck’s total North American business.
The global fetal bovine serum market is segmented on the basis of product, application, end user, and geography. Based on product, the global fetal bovine serum market is segmented into Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum (FBS), Exosome Depleted, Stem Cell, and others. Based on application, the global fetal bovine serum market is segmented into drug discovery, cell culture media, in vitro fertilization, human & animal vaccine production, and others. Based on end user, the global fetal serum market is segmented into biotechnology & pharmaceutical manufacturers, and academic institute, and research Laboratory. Based on geography, the global fetal bovine serum market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
Additionally, the study provides in-depth analysis of prominent players holding major share in the market with a focus on all operating business segment, and would identify the segment of the company focusing on fetal bovine serum products. Further, market share of company in the global fetal bovine serum market would also be calculated. For instance, Thermo Fisher Scientific operates through four business segments namely, analytical instruments, life sciences solutions, laboratory products & services, and specialty diagnostics. Fetal bovine serum is marketed under cell culture & transfection segment of the life sciences business. The life sciences business segment occupied about 26% share in the total business revenue for Thermo Fisher Scientific.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the fetal bovine serum companies. Furthermore, the global fetal bovine serum market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the fetal bovine serum market business segment of the company.
Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global fetal bovine serum market arena. For instance, in 2017, GE Healthcare and Oritain launched an independent test-based traceability program to authenticate the country of origin of Fetal Bovine Serum (FBS). This development was in line with the companies’ effort to combat serum frauds encountered by cell therapy firms. Key players in the global fetal bovine serum market are strongly focusing on enhancing the quality of their products and launching diversified range of products to lure consumers thereby strengthening their fetal bovine serum business.
By Product
By Application
By End user
By Geography
The global Fetal Bovine Serum market segmented on the basis of product, application, end user, and geography.
Major players operating in the global Fetal Bovine Serum market include Merck KGaA, Bovogen Biologicals Pty Ltd, Atlanta Biologicals Inc. (Bio-Techne Corporation), Thermo Fisher Scientific, GE Healthcare, Tissue Culture Biologicals, HiMedia Laboratories, TCS Biosciences Ltd., Rocky Mountain Biologicals and PAN-Biotech..
The base year considered in Fetal Bovine Serum market report is 2021.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved